Myelodysplastic Syndrome Clinical Trial
Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101)
Summary
This is an open-label, two-arm, phase III non-inferiority trial to evaluate the safety of a liberalized hospital diet inclusive of fresh fruits and vegetables to a neutropenic diet in patients with prolonged neutropenia. Both cohorts and diets will adhere to the hygiene and common sense advice listed in the FDA-endorsed food safety guidelines.
Eligibility Criteria
Inclusion Criteria:
Age 18 years or older
Undergoing treatment for hematologic malignancies or HSCT as outlined below:
Underlying diagnosis for non-HSCT patients:
Acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) receiving induction or reinduction chemotherapy; OR
Acute lymphoblastic leukemia (ALL) receiving an intensive induction chemotherapy (e.g., HyperCVAD±R, CALGB9251, Larsons protocol) with an expected duration of neutropenia of ≥7 days; OR
Allogeneic or autologous HSCT for any indication. For patients undergoing reduced intensity conditioning, only those regimens in which the expected neutropenia is ≥ 7 days are permitted and the patient must reside in the hospital
Expected duration of neutropenia of ≥ 7 days
Exclusion Criteria:
Use of anti infectives for treatment of active systemic infections within 7 days prior to initiation of study diet
Untreated major infection at presentation
Patients with uncontrolled invasive fungal infection (defined as those who have not completed at least 6 weeks of treatment; or who are symptomatic with two CT scans, at least 1 week apart showing uncontrolled disease at the time of initiation of study diet)
Uncontrolled HIV, Hepatitis B and C infection
Receipt of nutrition via enteral tube or total parenteral nutrition at the time of enrollment
Patients unwilling to eat fresh fruit and/or vegetables
Planned management of neutropenia in the outpatient setting
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Gainesville Florida, 32608, United States
How clear is this clinincal trial information?